A PHASE I STUDY OF VORINOSTAT, LENALIDOMIDE, AND DEXAMETHASONE FOR RELAPSED AND REFRACTORY MULTPLE MYELOMA

被引：0
|
作者：
Richardson, P. [1 ]
Weber, D. [2 ]
Mitsiades, C. [1 ]
Dimopoulos, M. [3 ]
Harousseau, J. L. [4 ]
Howe, J. [5 ]
Graef, T. [5 ]
Gause, C. [5 ]
Byrne, C. [6 ]
Anderson, K. [1 ]
Siegel, D. [7 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Athens, Sch Med, Athens, Greece
[4] Ctr Rene Gauducheau, St Herblain, France
[5] Merck & Co Inc, Upper Gwynedd, NJ USA
[6] Celgene Corp, Summit, NJ USA
[7] Hackensack Univ, Ctr Med, Hackensack, NJ USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0385
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: A phase I study
    Siegel, D. S.
    Weber, D. M.
    Mitsiades, C. S.
    Dimopoulos, M. A.
    Harousseau, J. L.
    Rizvi, S.
    Howe, J.
    Reiser, D.
    Anderson, K. C.
    Richardson, P. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] A Phase I Study of Vorinostat in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
    Siegel, David
    Weber, Donna
    Mitsiades, Constantine S.
    Rizvi, Syed
    Garcia-Vargas, Jose
    Howe, Jason
    Reiser, David
    Anderson, Kenneth C.
    Richardson, Paul
    [J]. BLOOD, 2008, 112 (11) : 1270 - 1270
  • [3] Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Vesole, David H.
    Bilotti, Elizabeth
    Richter, Joshua R.
    McNeill, Ann
    McBride, Laura
    Raucci, Laura
    Anand, Palka
    Bednarz, Urszula
    Ivanovski, Kristin
    Smith, Judith
    Batra, Veena
    Aleman, Adolfo
    Sims, Taliah
    Guerrero, Laura
    Mato, Anthony
    Siegel, David S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (01) : 52 - 59
  • [4] A phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone (QUAD) in relapsed and/or refractory multiple myeloma (MM).
    Vesole, David H.
    Siegel, David Samuel DiCapua
    Richter, Joshua Ryan
    McNeill, Ann
    Anand, Palka
    Bednarz, Urszula
    Ivanovski, Kristin
    McBride, Laura
    Raucci, Laura
    Batra, Veena
    Aleman, Adolfo
    Sims, Taliah
    Guerrero, Laura
    Smith, Judith
    Mato, Anthony R.
    Bilotti, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] COMBINED VORINOSTAT, LENALIDOMIDE AND DEXAMETHASONE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A PHASE I STUDY
    Siegel, D.
    Weber, D.
    Mitsiades, C.
    Dimopoulos, M.
    Harousseau, J.
    Rizvi, S.
    Howe, J.
    Reiser, D.
    Anderson, K.
    Richardson, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 155 - 155
  • [6] Combined Vorinostat, Lenalidomide and Dexamethasone Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase I Study
    Siegel, David
    Weber, Donna M.
    Mitsiades, Constantine S.
    Dimopoulos, Meletios A.
    Harousseau, Jean-Luc
    Rizvi, Syed
    Howe, Jason
    Reiser, David
    Byrne, Catriona
    Anderson, Kenneth C.
    Richardson, Paul
    [J]. BLOOD, 2009, 114 (22) : 129 - 129
  • [7] Salvage Therapy with Vorinostat, Lenalidomide, and Dexamethasone (ZRD) in Lenalidomide/Dexamethasone Relapsed/Refractory Multiple Myeloma
    Richter, Joshua R.
    Bilotti, Elizabeth
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Tufail, Madiha
    Anand, Palka
    McNeill, Ann
    Bednarz, Urszula
    Graef, Thorsten
    Vesole, David H.
    Siegel, David S.
    [J]. BLOOD, 2011, 118 (21) : 1706 - 1706
  • [8] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    [J]. BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [9] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    [J]. Blood Cancer Journal, 2014, 4 : e182 - e182
  • [10] PRELIMINARY RESULTS OF A PHASE I/II STUDY OF CARFILZOMIB, LENALIDOMIDE, VORINOSTAT AND DEXAMETHASONE (QUAD) IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (MM)
    Bilotti, El
    Vesole, D.
    Richter, J.
    McNeill, A.
    Anand, P.
    Bednarz, U.
    Ivanovski, K.
    McBride, L.
    Raucci, L.
    Batra, V.
    Siegel, D.
    [J]. HAEMATOLOGICA, 2013, 98 : 323 - 324
12345